Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Advances in hypertension as reported at ACC 2025 include two new therapies that achieve significant blood pressure (BP) reduction, and a comparison of renal denervation methods for resistant BP.

A research team has investigated structural changes in kidneys of patients with hypertension and type 2 ... type 2 diabetes are among the most common causes of chronic kidney disease.

A research team from the Medical University of Vienna has investigated structural changes in kidneys of patients with hypertension ... are among the most common causes of chronic kidney disease.

A group of 29 international experts says that simultaneous screening for hypertension and heart arrhythmia could prevent thousands of strokes. A recent expert review highlights the strong link ...

Pulmonary arterial hypertension (PAH) is a type of pulmonary hypertension that causes high blood pressure in the small arteries of the lungs. It is a serious condition that can impair blood flow ...

Managing hypertension with medication can mitigate dementia risk but does not eliminate it. Researchers do not fully understand the direct causes of hypertension, Daugherty said. “Our current ...